Lee E. Morrow, M.D., M.Sc

Lee E. Morrow, M.D., M.Sc.

CreightonUniversityMedicalCenter

Division of Pulmonary and Critical Care Medicine

601 North 30th Street, Suite 3820

Omaha, NE 68131

Work Phone: (402) 449-4486

Pager: (402) 956-5824

FAX: (402) 280-5256

E-mail:

Professional Experience

• Assistant Professor of Medicine, CreightonUniversitySchool of Medicine

- January 1, 2003, to present

- 20% Patient Care, 80% Clinical Research

• Assistant Professor of Pharmacy, CreightonUniversitySchool of Pharmacy and Health Professions

- October 17, 2006, to present

- Secondary appointment

• Clinical Instructor of Medicine, WashingtonUniversitySchool of Medicine

- July 1, 2002 - December 31, 2002

- 20% Patient Care, 80% Clinical Research

Clinical Training

Fellowship

• WashingtonUniversity, St. Louis, Missouri

- July 1, 1999 – June 30, 2002

- Board Certified, Pulmonary Medicine, November 6, 2002

- Board Certified, Critical Care Medicine, November 5, 2003

Residency

• MemorialMedicalCenter, Savannah, Georgia

- July 1, 1996 – June 30, 1999

- Board Certified, Internal Medicine, September 12, 1999

Education

MedicalSchool

• University of IowaCollege of Medicine, Iowa City, IA

M.D. (5/10/1996)

GraduateSchool

• University of Michigan, Ann Arbor, MI

M.Sc. in Clinical Research Design and Statistical Analysis (4/27/2003)

Undergraduate

• University of Michigan, Ann Arbor, MI

B.S. in Biology (5/1/1992)

Board Certification

• ABIM, Internal Medicine (1999 – Present)
• ABIM, Pulmonary Medicine (2002 – Present)

ABIM, Critical Care Medicine (2003 – Present)

ActiveHospital Privileges

• CreightonUniversityMedicalCenter, Omaha, NE (2003 – Present)
• MyrtueMemorialHospital, Harlan, IA (2005 – Present)
• BoysTownNationalResearchHospital, Omaha, NE (2007 – Present)
• MemorialCommunityHospital, Blair, NE (2007 – Present)

Continuing Education

• The Healthcare Associated Pneumonia Summit, Group Leader

Dallas, TX (12/15/2006 – 12/17/2006)

• Metro Omaha Medical Society’s Leadership Institute

Omaha, NE (10/21/2005 – 10/22/2005)

• CreightonUniversity “Teaching with Technology” Fellowship

Omaha, NE (2/9/2004 – 4/12/2004)

• Core Faculty, Creighton’s Center for Practice Improvement and Outcomes Research Omaha, NE (1/1/2003 – Present)
• National Lung Health Education “Train the Trainer” Program

Dallas, TX (6/26/2003)

• Practicum in Cardiopulmonary Exercise Testing

Harbor-UCLAMedicalCenter, Torrance, CA (3/27/2003)

Administration

Hospital Committees

• Member, Research Advisory Committee: 2007 – Present
• Member, CME Planning Subcommittee: 2006 – Present
• Member, Graduate Medical Education Committee: 2005 – Present
• Member, Health Sciences Research Committee: 2005 – Present
• Chairman, Pharmacy and Therapeutics Committee: 2005 – Present
• Member, Pharmacy and Therapeutics Committee: 2004 – Present

Professional Societies

• American Thoracic Society Critical Care Assembly Scientific Program Committee 2005 – Present
• Founder and Chair, Annual Integrating Evidence Based Pulmonary and Critical Care Medicine Into Clinical Practice CME Conference, 2005 – Present
• Co-Founder and Co-Chair, Omaha City-Wide Pulmonary Physicians Conference, 2003 – Present

Education

• Fellowship Program Director: July 2007 – Present
• Associate Fellowship Program Director: July 2005 – June 2007
• IDC 101 and IDC 102 (Molecular and Cellular Biology) Clinical Case Director and Faculty: 2004 – 2006
• Medicine 483 (Medical Statistics) Co-Course Master and Faculty: 2004 – Present
• Pulmonary and Critical Care Medicine Conference Director: 2003 – Present

Awards

Clinical Awards

• Guide to America’s Top Physicians, 2007
• Best of the U.S. Physicians, 2006
• Omaha’s Best Doctors, 2005
• Best Doctors in America, 2005
• WashingtonUniversity Pulmonary & Critical Care Chief Fellow, 2001-2002
• Memorial Medical Center Hospital-Wide Resident of the Year Award, 1999
• Memorial Medical Center Department of Internal Medicine Resident of the Year Award, 1999
• MemorialMedicalCenter Internal Medicine Chief Resident, 1998-1999

Research Awards

• CHEST Foundation Young Investigator Award, 2005
• Creighton University Department of Internal Medicine Excellence in Research Recognition, 2005
• Winner, National Research Poster Competition, AmericanCollege of Physicians 80th Annual Session, 1999
• Winner, AmericanCollege of Physicians Region IX Research Competition, 1999
• First Place, MemorialMedicalCenter Research Competition, 1999
• Winner, AmericanCollege of Physicians Region IX Research Competition, 1998
• First Place, MemorialMedicalCenter Research Competition, 1998
• American Federation for Clinical Research Award, 1994
• University of IowaCollege of Medicine Research Externship, 1993
• University of Michigan Department of Physiology Research Stipend, 1992
• University of Michigan Department of Physiology Research Stipend, 1991

Teaching Awards

• CreightonUniversityGolden Apple Nomination, 2006
• CreightonUniversity Internal Medicine Residents’ Teaching Service Award, 2005
• Creighton University Department of Internal Medicine Excellence in Medical Education Recognition, 2005
• Creighton University Golden Apple Nomination (two nominations), 2005
• CreightonUniversity Internal Medicine Residents’ Teaching Service Award, 2004
• CreightonUniversity Golden Apple Nomination, 2004
• Creighton University Department of Internal Medicine Excellence in Medical Education Recognition, 2004
• CreightonUniversity Golden Apple Nomination, 2003
• CreightonUniversity Internal Medicine Residents’ Teaching Service Award, 2003
• MercerUniversitySchool of Medicine Internal Medicine Teaching Resident of the Year, 1998-1999
• MercerUniversitySchool of Medicine Internal Medicine Teaching Resident of the Year, 1997-1998

Professional Society Awards

• CHEST Foundation Young Investigator Award, 2005
• AmericanCollege of Chest Physicians’ Humanitarian Recognition Award 2005
• Elected to Fellowship in the AmericanCollege of Chest Physicians, 2004
• AmericanCollege of Chest Physicians 5th Leadership Development for Academic Physicians Program Recipient, 2003

Peer Review Service

Scientific Journal Editorial Board

• Clinical Medicine: Respiratory and Pulmonary Medicine

Scientific Journal Reviews

• CHEST
• CME Scholar
• Critical Care Medicine
• European Journal of Clinical Microbiology & Infectious Diseases
• Neuropsychiatric Disease and Treatment
• Nutrition: The International Journal of Applied and Basic Nutritional Sciences
• Respiratory Care

Scientific Abstract Reviews

• AmericanCollege of Chest Physicians, Annual Program Assembly, Scientific Abstract Review Committee, 2005-Present
• American Thoracic Society, Critical Care Assembly, Scientific Program Abstract Review Committee, 2004-Present
• Society of Critical Care Medicine, Critical Care Congress, Congress Abstract Review Committee, 2007-Present

Academic Grant Reviews

• American Institute of Biological Science, Medical Research Program
• Health Future Foundation Faculty Development Grant
• Society of Critical Care Medicine, Research Committee

Peer-Reviewed Publications

• Morrow LE, Malesker MA. A 70-Year Old Woman With Septic Shock. Submitted to Chest: under peer review.
• Le R, Morrow LE. Obstructive Sleep Apnea. Submitted to MedScape General Medicine: under peer review.
• Cai W, Malesker MA, Morrow LE, Schuller D. Use of Methylxanthines to Improve Oxygenation Following Acute Cervical Spine Injury. Submitted to Annals of Pharmacotherapy: under review.
• Wear R, Morrow LE, Malesker MA. Limited Access to Effective Antidote Therapy in Acute Colchicine Overdose. Submitted to Pharmacotherapy: under review.
• Morrow LE, Kollef MH, Niederman MS, Leeper KV, Anzueto A. Predictors of Mortality in Patients with Ventilator Associated Pneumonia: A Multicenter Experience. Submitted to Critical Care Medicine: under review.
• Morrow LE. The Clinical and Microbiologic Features of Healthcare-Associated Pneumonia are More Similar to Hospital-Acquired Pneumonia than Community-Acquired Pneumonia. Clinical Infectious Diseases. In Press.
• Isakow W, Morrow LE, Kollef MH. Probioticsfor Preventing and Treating Nosocomial Infections: Review ofCurrent Evidence and Recommendations. Chest. 2007;132(1):286-294.
• Morrow LE, Malesker MA. The HCAP Handicap: What hospitalists need to know about healthcare-associated pneumonia. The Hospitalist. 2007;11(4):27-29.
• Morrow LE, Wear R, Malesker MA. Contemporary Limitations in the Management of Acute Isoniazid Toxicity with Pyridoxine. Pharmacotherapy. 2006;26(10):1529-32.
• Kollef M, Morrow LE, Niederman MS, Leeper KV, Anzueto A, Benz-Scott L, Rodino FJ. Clinical Characteristics and Treatment Patterns Among Patients With Ventilator-Associated Pneumonia. Chest. 2006;129(5):1210-8.
• Morrow LE, Malesker MA, Tilleman J. Management of Pulmonary Arterial Hypertension. Hospital Pharmacist. 2005;12(10):18-38.
• Farrington KL, Morrow LE. Antimicrobial Metals: A Non-Antibiotic Approach to Nosocomial Infections. Respiratory Therapy. 2005;18(9):22-26.

• Yusen RD, Morrow LE, and Brown KL. Health-Related Quality of Life After Lung Volume Reduction Surgery. Seminars in Thoracic and Cardiovascular Surgery. 2002;14(4):1-10.

• Morrow LE and Grimsley EW. Cardiology Quiz. Resident and Staff Physician. 2001;47(1):28.

• Acosta B, DiBenedetto R, Rahimi A, Acosta MF, Cuadra O, Van Nguyen A, and Morrow LE. Hemodynamic Effects of Non-Invasive Bilevel Positive Airway Pressure on Patients with Chronic Congestive Heart Failure with Systolic Dysfunction. Chest. 2000;118(4)1004-9.

• Morrow LE, Grimsley EW.Long-Term Diuretic Therapy in Hypertensive Patients: Effects on Serum Homocysteine, Vitamin B-6, Vitamin B-12, and Red Blood Cell Folate Concentrations. Southern Medical Journal. 1999;92(9):866-70.
• Morrow LE, McClellan JL, Klir JJ, Kluger MJ. The CNS site of glucocorticoid negative feedback during LPS- and psychological stress-induced fevers. American Journal of Physiology. 1996;271(3 Pt 2):R732-7.
• McClellan JL, Klir JJ, Morrow LE, Kluger MJ. Central effects of glucocorticoid receptor antagonist RU-38486 on lipopolysaccharide and stress-induced fever. American Journal of Physiology. 1994;267(3 Pt 2):R705-11.
• Morrow LE, McClellan JL, Conn CA, Kluger MJ. Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. American Journal of Physiology. 1993;264(5 Pt 2):R1010-6.

Invited Publications

• Morrow, LE. ICU Syndrome. Audio-Digest Psychiatry. 2007;36(18).
• Morrow LE, Malesker MA. Acid-Base Disturbances. In: Chisolm-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, Rotschafer JC, DiPiro JT. Pharmacotherapy Principals and Practice. New York: McGraw Hill. 2007.
• Malesker MA, Morrow LE. Fluids and Electrolytes. In: Chisolm-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, Rotschafer JC, DiPiro JT. Pharmacotherapy Principals and Practice. New York: McGraw Hill. 2007.
• Morrow LE, Schuller D. Tracheobronchitis in the ICU, in Infectious Diseases in Critical Care. Springer Press. New York. 2007.
• Shifren A,Morrow LE. Interstitial Lung Diseases, in The Washington Manual Subspecialty Consult Series: Pulmonary Medicine Subspecialty Consult. Lippincott, Williams and Wilkins. New York. 2006.
• Schuller D,Morrow LE. Pulmonary Complications Following Coronary Revascularization. Current Opinions in Cardiology. 2000;15:309-15.
• Morrow LE. Homocysteine: More Questions than Answers. Nutrition. 2000;16(9):780-1.

Abstracts

• Morrow LE, Vennapusa F, Vanderloo M, Malesker MA. Epidemiology of Renal Insufficiency in Geriatric Patients with Ventilator-Associated Pneumonia. Chest. In press.
• Morrow LE, Vennapusa F, Vanderloo M, Malesker MA. Epidemiology of Renal Insufficiency in Patients with Ventilator-Associated Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2007:175;A325.
• Morrow LE, Malesker MA, Farrington KL. Diagnostic Criteria and Intensity of Surveillance Affect Reportable Ventilator-Associated Pneumonia Rates. Chest. 2006:130(4);101S.
• Malesker MA, Morrow LE, Hilleman D. Cost-Effectiveness of Intensive Insulin Therapy in Critically Ill Patients: A Meta-Analysis. Critical Care Medicine. 2005:33(12);A83.
• Morrow LE, Kollef MH, Leeper KV, Anzueto A, Benz-Scott L, Rodino FJ, Niederman MS. Predictors of Death Among Patients with Ventilator-Associated Pneumonia. Chest. 2005:128(4);142S.
• Morrow LE, Kollef MH, Bowers JB, Casale TB. Probiotic Manipulation of the Native Flora in Critically Ill Patients: An Opportunity for Ventilator-Associated Pneumonia Prophylaxis? Chest. 2005:128(4);144S.
• Kollef MH, Leeper KV, Anzueto A, Morrow LE, Benz-Scott L, Rodino F, Niederman MS. Clinical and Treatment Patterns Among 398 Patients with Ventilator-Associated Pneumonia: Final Results of the Assessment of Local Antimicrobial Resistance Measures (ALARM) Study. Chest. 2005:128(4);142S.
• Chakinala MM, Hachem RR,Morrow LE, Yusen RD, PattersonGA, Trulock EP. Long-Term Outcomes of Single and Bilateral Lung Transplantation for Adults with Pulmonary Arterial Hypertension. Journal of Heart and Lung Transplantation. 2005:24(2);S55.
• Kollef MH, Niederman MS, Leeper KV, Morrow LE, Anzueto A, Benz-Scott L, Rodino F. Escalation/De-escalation of Initial Empiric Ventilator Associated Pneumonia Therapy. Chest. 2004:126(4);718S.
• Sankarapandian B, ThambidoraiSK, Bandara M, Dodla S, Morrow LE. Colchicine Overdose: Not Just Diarrhea. Journal of General Internal Medicine. 2004;19(Supp. 1);43.
• Ryan SC, Morrow LE, Meyers BF, Thompson P, Hachem RR, Chakinala MM, Patterson GA, Trulock EP, Yusen RD. The Impact of Lung Transplantation on the Survival of Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2004:169(7);A269.
• Sankarapandian B, Marsh A, Bandara M, Thambidorai S, Morrow LE, Lund R, Dunlay R. Complex Acid-Base Disturbance in a Pregnant Female. American Journal of Kidney Disease. 2004;43:A41.
• Morrow LE, Trulock EP, Thompson P, Bennett L, Yusen RD. Survival of Patients with Primary Pulmonary Hypertension Wait-Listed for Lung Transplant. American Journal of Respiratory and Critical Care Medicine. 2003;167(7);A611.
• Morrow LE, Trulock EP, Meyers BF, Patterson GA, Scavuzzo M, Yusen RD. Predictors of Death for Patients with Primary Pulmonary Hypertension Wait-Listed for Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 2002;165(7);A559.

Completed Research Support - Government

• Role: Fellow (PI: Michael J. Holtzman, MD, Dept. of Medicine)

Source: NIH-National Heart, Lung and Blood Institute, 5 T32 HL007317-24

Type: Federal training grant

Title: Institutional National Research Service Award

Dates: January 1, 2001 – December 31, 2002

• Role: Research Trainee (PI: Donald Heistad, MD)

Source: NIH-National Heart, Lung and Blood Institute, 5 T35 HL007485-14

Type: Federal training grant

Title: Short-Term Institutional Research Training Grant

Dates: May 1, 1993 – July 31, 1993

Completed Research Support - Private

• Role: Primary Investigator

Source: CreightonUniversity Health Futures Foundation

Type: University-sponsored, investigator-initiated, single center trial

Title: Probiotic Prophylaxis of Ventilator Associated Pneumonia

Dates: August 1, 2003 – July 31, 2006Role: Primary Investigator

• Role: Primary Investigator

Source:The Association of Subspecialty Professors – The AmericanCollege of Chest Physicians

Type: Private foundation-sponsored, investigator-initiated, single center trial

Title: A Multidisciplinary Intervention to Optimize the Recovery of Elderly Patients Hospitalized with Community Acquired Pneumonia

Dates: July 1, 2004 – June 30, 2006

• Role: Primary Investigator

Source: C.R. Bard Inc.

Type: Industry-sponsored, multicenter trial

Title:Multicenter Clinical Trial of the Bard Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP). Protocol Number 5003A

Dates: July 1, 2003 – March 10, 2006

• Role: Subinvestigator

Source: Johnson and Johnson Pharmaceutical Research & Development

Type: Industry-sponsored, multicenter trial

Title: A randomized, double blind, placebo-controlled study to determine the efficacy and safety of epoetin alfa in critically ill subjects

Dates: January 20, 2005 – December 31, 2005

• Role: Subinvestigator

Source: Discover Laboratories, Inc.

Type: Industry-sponsored, multicenter trial

Title: A multicenter, randomized, controlled trial comparing the safety and effectiveness of surfaxin (lucinactant) delivered via bronchopulmonary segmental lavage to standard of care in patients with acute respiratory distress syndrome (ARDS)

Dates: January 19, 2005 – December 31, 2005

• Role: Primary Investigator

Source: Elan Pharmaceuticals, Inc.

Type: Industry-sponsored, multicenter trial

Title: Assessment of Local Antimicrobial Resistance Measures (ALARM)

Dates: July 1, 2003 – December 31, 2004

• Role: Primary Investigator

Source: Spanish Health Institute

Type: Foreign foundation-sponsored, multicenter trial

Title: Second International Study of Mechanical Ventilation

Dates: April 1, 2004 – April 30, 2004

• Role: Subinvestigator

Source: Organon, Inc.

Type: Industry-sponsored, multicenter trial

Title: A multicenter, multinational, randomized, open-label study comparing the efficacy and safety of once daily Org31540/SR90107A versus adjusted-dose intravenous unfractionated heparin in the initial treatment of acute symptomatic pulmonary embolism. Study Number 63123

Dates: 2000 – 2002

• Role: Subinvestigator

Source: Sanofi-Synthelabo, Inc.

Type: Industry-sponsored, multicenter trial

Title:A multicenter, randomized, double-blinded study comparing the efficacy and safety of once daily Org31540/SR90107A versus twice daily enoxaparin in the initial treatment of acute symptomatic deep venous thrombosis. Protocol Number ECF 2441

Dates: 2000 – 2002

• Role: Subinvestigator

Source: Rhone Poulenc Rorer Pharmaceutical

Type: Industry-sponsored, multicenter trial

Title:Open-Label, Comparative, Randomized, Multicenter Phase III Study of Intravenous Treatment of Synercid 7.5 mg/kg q 8 Hours Plus Aztreonam 2 g q 8 Hours versus Standard Therapy in the Treatment of 190 Adult Evaluable Hospitalized Patients with Nosocomial Pneumonia Due, at Least in Part, to Gram Positive Cocci

Dates: July 1, 1998 – June 30, 1999

• Role: Subinvestigator

Source: Roche Pharmaceuticals

Type: Industry-sponsored, multicenter trial

Title:A Prospective, Open-Label, Randomized by Physician, Parallel Group, Multicenter Study to Asses the Pharmacoeconomic and Medical Outcomes in Patients with Community Acquired Pneumonia Treated with a Practice Guideline Recommending Early Hospital Discharge Facilitated with the Use of Rocephin Versus a Regimen of “Usual Care”

Dates: July 1, 1998 – June 30, 1999

• Role: Subinvestigator

Source: Astra Zeneca International

Type: Industry-sponsored, multicenter trial

Title:Multicenter Nonrandomized Trial of Intravenous Merrem (Meropenem, ICI 194,660) for the Treatment of Hospital Acquired Pneumonia

Dates: July 1, 1998 – June 30, 1999

Current Research Support - Government

• Role: Primary Investigator

Source: NIH-National Heart, Lung and Blood Institute, 1 K23 HL84191-01

Type: Federal career-development award

Title: Probiotic Prophylaxis of Ventilator Associated Pneumonia

Dates: August8, 2005 – August7, 2010

• Role: Primary Investigator

Source: LB-691 (The Nebraska Tobacco Settlement)

Type: Private foundation-sponsored, investigator-initiated, single center trial

Title: Probiotic Prophylaxis of Pneumonia

Dates: November 1, 2004 – Present

Current Research Support - Private

• Role: Primary Investigator

Source: Ortho-McNeil Janssen, LLC

Type: Industry-sponsored, multicenter trial

Title: A phase 2, open-label, non-comparative study of Doripenem in the treatment of nosocomial and ventilator-associated pneumonia in hospitals where Pseudomonas aeruginosa may be a prevalent pathogen (Protocol Number: DORIINI2002; Phase 2)

Dates: July 1, 2007 – Present

• Role: Primary Investigator

Source: ALTANA Pharma AG

Type: Industry-sponsored, multicenter trial

Title: Venticute in patients with pneumonia or aspiration of gastric contents leading to intubation, mechanical ventilation, and severe oxygenation impairment (The VALID Study)

Dates: May 1, 2007 – Present

• Role: Subinvestigator

Source: ALTANA Pharma AG

Type: Industry-sponsored, multicenter trial

Title: Effect of Roflumilast on exacerbation rate in patients with COPD. The HERMES Study

Dates: January 1, 2006 – Present

• Role: Primary Investigator

Source: Pfizer, Inc.

Type: Industry-sponsored, multicenter trial

Title: Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to Methicillin-resistant Staphylococcus aureus (The ZEPHyR Study)

Dates: November 1, 2005 – Present

• Role: Primary Investigator

Source: Hospira Global Medical Affairs

Type: Industry-sponsored, multicenter trial

Title: A phase 4, randomized, double-blind, multi-center, comparator study evaluating the safety and efficacy of dexmedetomidine compared to IV midazolam in ICU subjects requiring greater than 24 hours of continuous sedation

Dates: September 28, 2005 – Present

• Role: Subinvestigator

Source: GlaxoSmithKline

Type: Industry-sponsored, multicenter trial

Title: Randomized double-blind parallel group 52-week study to compare the effect of the Fluticasone propionate/Salmeterol discus combination product 250/50 mcg BID with Salmeterol discus 50 mcg bid on the annual rate of moderate/severe exacerbations in subjects with chronic obstructive pulmonary disease

Dates: January 14, 2005 – Present

Scientific Meeting Presentations

• Poster Presentation, “Epidemiology of Renal Insufficiency in Geriatric Patients with Ventilator-Associated Pneumonia.” AmericanCollege of Chest Physicians, Chicago, IL, 2007.
• Poster Presentation and Thematic Poster Discussion, “Epidemiology of Renal Insufficiency in Patients with Ventilator-Associated Pneumonia.” American Thoracic Society, San Francisco, CA, 2007.
• Thematic Poster Session Moderator, “ICU Management and Outcomes.” American Thoracic Society, San Francisco, CA, 2007.
• Plenary Session Research Presentation, “The Benefits of Probiotics in Critical Care.” Society of Critical Care Medicine, Orlando, FL, 2007.
• Poster Presentation, “Prescription Stimulant Abuse and Cardiac Arrest.” Society of Critical Care Medicine, Orlando, FL, 2007.
• Poster Presentation, “Cost Effectiveness of Intensive Insulin Therapy in Critically Ill Patients: A Meta-Analysis.” AmericanCollege of Clinical Pharmacy, St. Louis, MO, 2006.
• Oral Research Presentation, “Diagnostic Criteria and Intensity of Surveillance Affect Ventilator-Associated Pneumonia Rates.” AmericanCollege of Chest Physicians, Salt Lake City, UT, 2006.
• Poster Session Moderator, “Miscellaneous Topics in Sepsis.” American Thoracic Society, San Diego, CA, 2006.
• Poster Presentation, “Effects of The Pneumonia Specific Geriatric Assessment on Hospital Length of Stay and Return to Independent Living.” American Geriatrics Society, Chicago, IL, 2006.
• Poster Presentation, “Cost Effectiveness of Intensive Insulin Therapy in Critically Ill Patients: A Meta-Analysis.” Society of Critical Care Medicine, San Francisco, CA, 2006.

• Oral Research Presentation, “Predictors of Death Among Patients with Ventilator-Associated Pneumonia.” AmericanCollege of Chest Physicians, Montreal, Canada, 2005.

• Oral Research Presentation, “Probiotic Manipulation of the Native Flora in Critically Ill Patients: An Opportunity for Ventilator-Associated Pneumonia Prophylaxis?” AmericanCollege of Chest Physicians, Montreal, Canada, 2005.
• Oral Research Presentation, “Lactobacillus rhamnosus GG Prophylaxis of Ventilator Associated Pneumonia.” AmericanCollege of Chest Physicians, Montreal, Canada, 2005.
• Symposium Chair, “Beyond Antibiotic Therapy: A New Look at Ventilator Associated Pneumonia.” American Thoracic Society, San Diego, CA, 2005.
• Plenary Session Research Presentation, “Probiotic Prophylaxis of Ventilator Associated Pneumonia.” American Thoracic Society, San Diego, CA, 2005.
• Poster Presentation, “The Pneumonia Specific Geriatric Assessment.” American Geriatrics Society, Orlando, FL, 2005.
• Oral Research Presentation, “Long-Term Outcomes of Single and Bilateral Lung Transplantation for Adults with Primary Pulmonary Hypertension.” International Society for Heart and Lung Transplant, San Diego, CA, 2005.
• Oral Research Presentation, “Escalation and De-Escalation of Initial Empiric Ventilator Associated Pneumonia Therapy: Interim Results from the Assessment of Local Antimicrobial Resistance Measures (ALARM) Study.” AmericanCollege of Chest Physicians, Seattle, WA, 2004.
• Research Poster Presentation, “Survival Effects of Lung Transplantation of Patients with Cystic Fibrosis.” American Thoracic Society, Orlando, FL, 2004.
• Oral Clinical Vignette Presentation, “Colchicine Overdose – Not Just Diarrhea.” Society of General Internal Medicine, Chicago, IL, 2004.
• Clinical Vignette Poster Presentation, “An Unusually Complex Acid-Base Disturbance in a Pregnant Female.” National Kidney Foundation, Chicago, IL, 2004.
• Research Poster Presentation, “Survival Effects of Lung Transplantation of Patients with Cystic Fibrosis.” International Society for Heart & Lung Transplantation, San Francisco, CA, 2004.
• Research Poster Presentation, “Survival of Patients with Primary Pulmonary Hypertension Wait-Listed for Lung Transplantation.” American Thoracic Society, Seattle, WA, 2003.
• Research Poster Presentation, “Predictors of Lung Transplant Wait-List Survival for Patients with Primary Pulmonary Hypertension.” American Thoracic Society, Atlanta, GA, 2002.
• Research Poster Competition, “Long-Term Diuretic Therapy in Hypertensive Patients: Effects on Homocysteine, Vitamin B-6, Vitamin B-12, and Red Blood Cell Folate Concentrations.” 80th Annual Session of AmericanCollege of Physicians, New Orleans, LA, 1999.
• Oral Research Presentation, “Hemodynamic Effects of Non-Invasive Bilevel Positive Airway Pressure on Patients with Chronic Congestive Heart Failure with Systolic Dysfunction.” AmericanCollege of Physicians Regional Meeting, Atlanta, GA, 1999 .
• Oral Clinical Vignette Presentation, “Malignant Degeneration of Tracheobronchial Papillomatosis.” AmericanCollege of Physicians Regional Meeting, Atlanta, GA, 1999.
• Research Poster Presentation, “Long-Term Diuretic Therapy in Hypertensive Patients: Effects on Homocysteine, Vitamin B-6, Vitamin B-12, and Red Blood Cell Folate Concentrations.“ Southern Medical Association Annual Session, New Orleans, LA, 1998.
• Research Poster Presentation, “Long-Term Diuretic Therapy in Hypertensive Patients: Effects on Homocysteine, Vitamin B-6, Vitamin B-12, and Red Blood Cell Folate Concentrations.“ AmericanCollege of Physicians Regional Meeting, Savannah, GA, 1998.

• Research Poster Presentation, “The CNS Site of Glucocorticoid Negative Feedback During LPS- and Psychological Stress-Induced Fevers.” Federation of American Societies for Experimental Biology, Los Angeles, CA, 1992.

Invited CME Presentations